Phytochemical Properties and Cardiovascular Applications of Terminalia Arjuna

Terminalia arjuna, a deciduous tree indigenous to the Indian subcontinent, has been extensively studied for its rich array of bioactive constituents and their cardioprotective potential. The bark of T. arjuna contains high concentrations of polyphenols, flavonoids, tannins and oleanane‐type triterpenoids, together with minerals such as magnesium and calcium. These phytochemicals act synergistically to scavenge reactive oxygen species, inhibit lipid peroxidation and modulate inflammatory pathways implicated in atherosclerosis. Experimental models demonstrate that T. arjuna extracts improve endothelial function, reduce serum cholesterol and triglyceride levels, and attenuate the progression of coronary artery plaque. Mechanistic investigations have implicated suppression of pro‐inflammatory cytokines, inhibition of angiotensin‐converting enzyme activity and upregulation of endogenous antioxidant enzymes. Advances in extraction technology and formulation science have yielded nanoparticle suspensions and polymeric delivery systems that enhance the bioavailability and stability of key constituents. Collectively, these findings underscore the global significance of T. arjuna as a source of lead compounds for the prevention and treatment of cardiovascular disease.

Research from Nature Portfolio

Recent studies have undertaken comprehensive profiling of solvent extracts of T. arjuna bark to characterise antioxidant capacity and DNA‐nicking inhibition. Ethanol and methanol fractions exhibited the highest total phenolic and flavonoid contents, correlating with potent free‐radical scavenging in DPPH, FRAP and ABTS assays. Detailed chemometric analysis established a strong association between polyphenol concentration and inhibition of H₂O₂‐induced DNA damage. High‐resolution mass spectrometry identified gallic acid and ellagic acid as dominant constituents, while novel steroidal compounds were detected in non‐polar fractions. This work provides a methodological framework for selecting optimal extraction solvents and lays the groundwork for developing herbal formulations that protect genomic integrity under oxidative stress.

Phytochemical Properties and Cardiovascular Applications of Terminalia Arjuna publication trend

The graph below shows the total number of articles in phytochemical properties and cardiovascular applications of terminalia arjuna across all publications each year (not limited to Nature Index journals).

Technical terms

Polyphenols: A diverse group of plant metabolites characterised by multiple phenolic rings, responsible for antioxidant activity.

Flavonoids: A subclass of polyphenols with a 15-carbon skeleton that modulate cell signalling and confer cardioprotection.

Triterpenoids: A class of terpenes composed of six isoprene units, noted for anti-inflammatory and lipid-lowering effects.

Atherosclerosis: A chronic vascular disease marked by plaque accumulation in arterial walls, leading to compromised blood flow.

Molecular docking: A computational technique to predict the preferred orientation of a small molecule when bound to a protein target.

Reactive oxygen species (ROS): Chemically reactive molecules containing oxygen that can damage cellular components if not neutralised.

References

1. Terminalia arjuna, a Cardioprotective Herbal Medicine–Relevancy in the Modern Era of Pharmaceuticals and Green Nanomedicine—A Review. Pharmaceuticals (2023).
2. Multitarget Potential of Phytochemicals from Traditional Medicinal Tree, Terminalia arjuna (Roxb. ex DC.) Wight & Arnot as Potential Medicaments for Cardiovascular Disease: An In-Silico Approach. Molecules (2023).
3. Anti‐Atherogenic Activity of Ethanolic Fraction of Terminalia arjuna Bark on Hypercholesterolemic Rabbits. Evidence-based Complementary and Alternative Medicine (2011).
4. On valorization of solvent extracts of Terminalia arjuna (arjuna) upon DNA scission and free radical scavenging improves coupling responses and cognitive functions under in vitro conditions. Scientific Reports (2021).